study question: Is a genetic risk score (GRS) associated with polycystic ovary syndrome (PCOS) and its related clinical features? summary answer: The GRS calculated by genome-wide association studies (GWASs) was significantly associated with PCOS status and
Introduction
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by oligomenorrhea, hyperandrogenism and polycystic ovary morphology (Conway et al., 2014) . PCOS is an extremely complex disorder that arises through a combination of heredity and environmental factors. The genetic influence of PCOS was suggested in previous studies, including those revealing familial clustering of PCOS and high heritability in twin studies (Legro et al., 1998; Vink et al., 2006) . Recent genome-wide association studies (GWASs) have identified a dozen loci associated with PCOS risk (Chen et al., 2011; Lee et al., 2015) . These GWASs were conducted in Chinese and Korean women and validated in other populations (Goodarzi et al., 2012; Welt et al., 2012; Zhao et al., 2012) . Although these individual single-nucleotide polymorphisms (SNPs) provide valuable information on the underlying pathophysiology, their effect sizes are very small and they contribute little to the heritable risk (Manolio et al., 2009) .
Genetic risk scores (GRSs) summarize disease-related variations across the genome (Horne et al., 2005) by aggregating information from multiple risk SNPs. GRSs appear to be a more realistic tool because they summarize the potential multiple risk genetic risk influences into a single parameter and do not depend on single genetic variants (Belsky et al., 2013) . Therefore, the GRS can be an efficient method of genome-wide risk assessment based on GWAS findings. To our knowledge, no previous epidemiological studies have evaluated the GRS in women with PCOS.
In the present study, we investigated whether the GRS based on SNPs, which were identified in previous PCOS-GWASs, was associated with a PCOS and its related clinical features.
Methods

Subjects
We recruited 862 women with PCOS and 860 controls in the Korean population. The volunteers were recruited by local advertising at the Endocrinology and Gynecology Clinics at Ewha Womans University Hospital between December 2008 and October 2010. After excluding those who did not meet the eligibility criteria, we invited volunteers to visit our hospital on the morning of the third day of their menstrual period, following an overnight fast of at least 8 h. We explained the purpose and characteristics of the study and obtained signed informed consent. The institutional review board of Ewha Womans University Medical Center approved this study.
As proposed at the American Society for Reproductive Medicine (ASRM) and the European Society for Human Reproduction and Embryology (ESHRE) consensus meeting (Franks and McCarthy, 2004) , PCOS was diagnosed by the presence of two or more of the following three criteria: oligomenorrhea, hyperandrogenism and polycystic ovaries. Oligomenorrhea is defined as fewer than eight menstrual cycles per year. Biochemical hyperandrogenemia is defined as a total or free testosterone level above the 95th percentile (total testosterone ≥67 ng/dl or free testosterone ≥0.84 ng/dl) based on the testosterone levels in 1120 healthy, regular-cycling women (Vermeulen et al., 1999) . Clinical hyperandrogenism is defined as hirsutism with a modified Ferriman-Gallwey (mFG) score of ≥3 (Escobar-Morreale et al., 2012). The diagnosis of polycystic ovaries requires the visualization of ≥12 follicles/ovary that are 2 -9 mm in diameter or an ovarian volume of .10 cm 3 based on transvaginal ultrasonography. Individuals with specific disorders such as adult-onset congenital adrenal hyperplasia, hyperprolactinemia and androgen-secreting neoplasia were excluded from our study. Patients taking medications (e.g., steroids, oral contraceptives, metformin or thiazide diuretics) before starting the study were excluded. None of the controls had a family history of diabetes or PCOS. Subjects were excluded if they had been taking hormonal medication within 3 months of the evaluation or had used other drugs that could affect the basal parameter status. Women with PCOS were divided into four subgroups: (1) oligomenorrhea + hyperandrogenism + polycystic ovary, (2) oligomenorrhea + hyperandrogenism, (3) oligomenorrhea + polycystic ovary and (4) hyperandrogenism + polycystic ovary.
Assays and ultrasound method
Height and weight were measured in all the subjects, and BMI was calculated as weight (kg)/height (m) 2 . Waist circumference was measured at the narrowest indentation between the 10th rib and the iliac crest at mid-respiration. Hirsutism was assessed using the mFG scoring method by one trained nurse.
After an overnight fast of at least 8 h, a venous blood sample was obtained from each subject on the third day of the follicular phase of the menstrual cycle. In the case of amenorrhea, the sample was obtained on a random day, and we assessed the serum progesterone levels. The women with progesterone levels of ,4 ng/ml were considered anovulatory.
Ultrasound examinations were performed with a 7-MHz transvaginal transducer (Logic 400 General Electric, Milwaukee, WI, USA). Ovarian volume was calculated according to a simplified ellipsoid formula (0.5 × length × width × thickness) (Balen et al., 2003) . Ovarian volume was defined as the average volume of both ovaries, and the ovarian follicle number was defined as the average number of follicles in each ovary.
Total testosterone levels were measured via the chemiluminescence immunoassay method using a commercially available kit (Siemens, NY, USA), and sex hormone-binding globulin (SHBG) levels were measured by an immunoradiometric assay using a commercially available kit (DPC, Los Angeles, CA, USA). Free testosterone levels were calculated using the formula available on the International Society for Study of the Aging Male (ISSAM) website (http://www.issam.ch/freetesto.htm), which is based on the total testosterone, SHBG and albumin levels in the same sample from each subject (Vermeulen et al., 1999) .
The 75-g oral glucose tolerance test (OGTT) was performed in the morning after an overnight fast. A polyethylene catheter was placed into the antecubital vein before the test. After 30 min of supine rest, venous blood samples were drawn at baseline, 90 min and 120 min after the administration of the 75-g glucose load. Plasma glucose levels were measured via the glucose oxidase method (Beckman Model Glucose Analyzer 2, CA, USA), and insulin levels were measured by a radioimmunoassay using a commercially available kit (BioSource, Nivelles, Belgium). Insulin sensitivity was estimated based on the metabolic clearance rate (MCR) of glucose calculated from the OGTT according to the following formula: MCR ¼ 18.8-0.271 × BMI -0.0052 × I 120 -0.27 × G 90 (I 120 ; post-load 120-min insulin, G 90 ; post-load 90-min glucose). Fasting total serum cholesterol, triglycerides and high-density lipoprotein cholesterol levels were measured using an enzymatic assay performed with an automated analyzer (Hitachi 7150 Automatic Chemistry Analyzer, Japan).
Genotyping
Genomic DNA was extracted from an individual's peripheral blood and genotyped using the HumanOmni1-Quad v1 array (Illumina, San Diego, CA, USA). To select SNPs that could be combined to obtain a GRS, we used information from recently published PCOS-GWAS data. The previous GWASs reported 12 index SNPs associated with PCOS (Chen et al., 2011; Lee et al., 2015) , and we selected 11 SNPs that were present in our subjects.
SNPs in LH/CG receptor (LHCGR), thyroid adenoma associated (THADA) and DENN/MADD domain containing 1A (DENND1A) were found in the first GWASs in Han Chinese (Chen et al., 2011) . The LHCGR mutation was associated with increased LH-enlarged ovaries, oligomenorrhea and infertility. THADA was reported to be associated with type 2 diabetes in a European GWAS (Zeggini et al., 2008) . DENND1A might influence the pathogenesis of PCOS through misregulation of endoplasmic reticulum aminopeptidase I (Olszanecka-Glinianowicz et al., 2007) . FSH receptor (FSHR), chromosome 9 open reading frame 3 (C9orf3), Yes-associated protein 1(YAP1), RAB5B, member RAS oncogene family (RAB5B), TOX high mobility group box family member 3 (TOX3), insulin receptor (INSR) and SUMO1 pseudogene 1 (SUMO1P1) were identified in a second GWAS in Han Chinese . FSHR and C9orf3 were reported to be associated with the erectile dysfunction in men and PCOS in women (Kerns et al., 2010) . The YAP1 protein was associated with PCOS and had an important role in ovarian size control . RAB5B was associated with type 1 diabetes in previous studies (Barrett et al., 2009) . INSR had an important role in insulin resistance and was reported to be associated with PCOS (Siegel et al., 2002) . KH domaincontaining, RNA-binding, signal transduction-associated 3 (KHDRBS3) was found in a Korean GWAS (Lee et al., 2015) and was associated with telomerase activity and PCOS (Li et al., 2014) .
GRS calculation
A GRS was calculated by summing the number of the risk alleles for each of the included SNPs (2 for homozygous, 1 for heterozygous and 0 for absence of a risk allele), yielding total scores ranging from 0 to 22 for the 11-SNP GRS. A weighted GRS (wGRS) was calculated by multiplying the number of risk alleles for each SNP by its estimated effect (beta) obtained from the association analysis.
Statistical analysis
The chi-square test was used to assess whether the genotypes were in Hardy -Weinberg equilibrium (HWE) and all SNPs were in HWE. Quantitative variables are reported as the means + SD. The Kolmogorov-Smirnov statistic was used to analyze the continuous variables for normality, and logarithmic transformations were applied as necessary to ensure the normal distribution of skewed variables. Two groups with different parameters were compared using Student's unpaired t-test. A chi-square test was used to determine differences in genotype frequencies between PCOS cases and controls. The association of the 11 SNPs and GRS with PCOS was estimated using a logistic regression model, and the Bonferroni correction was used to control for multiple testing (P , 0.05/11 ¼ 0.0045). We divided the continuous GRS into quartiles and compared the risk between them (Quartile 1: 3 -5, Quartile 2: 6 -8, Quartile 3: 9 -11, Quartile 4: 12 -15). The differences in the parameters between the quartiles were analyzed by analysis of variance (ANOVA), followed by Tukey's honestly significant difference test for post hoc analysis. Four main PCOS phenotypes and controls with different parameters were compared using the one-way ANOVA. We used the Statistical Package for the Social Sciences 20.0 software package for Windows (IBM Corporation, Chicago, IL, USA) for all of the aforementioned analyses. A P , 0.05 was considered significant.
Results
We included 862 PCOS cases and 860 controls, with a mean age of 25 + 4 years in the present study. The clinical and biochemical characteristics of the individuals are described in Table I . Women with PCOS were younger and more likely to be obese than the controls. Women with PCOS exhibited higher free testosterone levels, mFG scores, post-load 2-h glucose levels, fasting insulin levels, post-load 2-h insulin levels, total cholesterol levels, triglycerides levels, ovarian follicle numbers and ovarian volumes. The MCR was significantly lower in women with PCOS (P , 0.05, Table I ). These differences persisted after adjustment for age and BMI. Table II shows a summary of the SNPs included in the calculation of the GRS. Among the 11 SNPs, 7 SNPs (rs10176989, rs13429458, rs2268361, rs10505648, rs1894116, rs705704 and rs11075466) showed significant associations with PCOS (P , 0.0045, Table II ). The GRS, representing the sum of the risk alleles, was significantly higher in women with PCOS after adjusting for age and BMI (Table I) .
Compared with the subjects in the first quartile of the GRS, subjects in the second quartile (odds ratio (OR) ¼ 1.76, 95% confidence interval (CI) ¼ 1.128-2.757, P ¼ 0.008), third quartile (OR ¼ 2.25, 95% CI ¼ 1.442-3.522, P ≤ 0.001) and fourth quartile (OR ¼ 6.28, 95% CI ¼ 3.309-11.913, P , 0.001) showed a significantly increased risk of PCOS (Table III) . The weighted GRS yielded similar results. The multiple regression analysis demonstrated that the GRS was significantly associated with free testosterone, menstruation number/ year, ovarian volume and ovarian follicle number after adjusting for age and BMI (Table IV) .
The subjects in the fourth quartile exhibited a lower menstruation number/year, and higher free testosterone levels, ovarian volumes and ovarian follicle numbers compared with the subjects in the first, second and third quartiles (Table V , in all cases, P , 0.05). Additionally, the MCR was significantly lower in subjects in the fourth quartile compared with those in the other groups (P , 0.05).
We compared GRS among four main PCOS phenotypes and controls. Women with phenotype A and C had significantly higher GRS than controls (8.8 versus 8.2, 9.1 versus 8.2, respectively, P , 0.01). The GRS of women with phenotype B (8.6) and D (8.5) did not differ from that of controls. Post-load glucose, fasting insulin and post-load insulin levels were significantly higher, and MCR was significantly lower among women in Groups A and B than those in Group C and controls (Table VI) . Figure 1 shows the trend of free testosterone level, menstruation number/year, ovarian volume and ovarian follicle number in different categories of GRS. We observed a positive association between free testosterone, ovarian volume, ovarian follicle number and the GRS and a negative association between menstruation number/year and the GRS (all P , 0.01).
Discussion
In the present study, we explored the association between the GRS and PCOS risk. The GRS based on 11 SNPs derived from previous GWASs was associated with PCOS risk. The subjects in the top GRS quartile had a 6.28-fold increased PCOS risk compared with those in the lowest quartile. Additionally, the GRS was associated with PCOS-related traits, including free testosterone, menstruation number/year and ovarian morphology. To our knowledge, this is the first study to investigate the relationship between the GRS and PCOS risk. We genotyped 11 PCOS-associated loci, and 7 of them (LHCGR, THADA, FSHR, KHDRBS3, YAP1, RAB5B and TOX3) showed a significant association with PCOS after Bonferroni correction. Most genotyped SNPs showed the same direction of effect as previously reported based on GWAS data (Chen et al., 2011; Lee et al., 2015) , except for the FSHR and INSR polymorphisms.
The inverse direction of these two SNPs may be due to the differences in linkage disequilibrium or environmental distinctions. Although the individual genetic effects are not strong, the combined effect of these loci showed a remarkable influence on PCOS risk. DENDD1A and INSR were strongly associated with PCOS risk in other studies (Chen et al., 2011; Goodarzi et al., 2012; Welt et al., 2012) ; however, these loci were not associated with PCOS risk in our study population. This difference was probably due to the ethnic diversity and different genotyping chips employed among studies.
PCOS is a heterogenous disorder, and genetic contribution is estimated to explain 65% of the risk of PCOS (Kosova and Urbanek, 2013) . Candidate gene association studies have been a general trend in the study of PCOS genetics, and recently, GWASs on PCOS were conducted in a Han Chinese and Korean population (Chen et al., 2011; Lee et al., 2015) . The 3 GWASs identified 12 risk loci for PCOS, and these loci were replicated in other ethnicities (Lerchbaum et al., 2011; Goodarzi et al., 2012) . GWAS is a powerful method for screening susceptible genes associated with complex Data are mean + SD. The differences in the parameters between the quartiles were analyzed by ANOVA, followed by Tukey's honestly significant difference test for post hoc analysis. C, cholesterol; FPG, fasting plasma glucose; FPI, fasting plasma insulin; Mens, menstruation; OFN, ovarian follicle number; OV, ovarian volume; PPG, post-load 2-h glucose; PPI, post-load 2-h insulin; T, testosterone; TG, triglycerides. diseases; however, GWASs mainly focus on individual SNPs and neglect the interaction of genes. Additionally, some identified SNPs lack functional relevance, explaining only a small portion of genetic heritability (Stringer et al., 2011) . Information from multiple SNPs is used to determine the GRS, and each individual SNP is less important to the GRS in the pooled analysis. Therefore, the GRS could be an effective method of constructing genome-wide risk measurements from GWAS datasets. PCOS is a complex disease, and the genetic basis is multifactorial; thus, informative variants are scattered across the entire genome and contribute only small effects. Therefore, information from multiple SNPs is required to determine the genetic susceptibility to PCOS. In our study, the GRS based on GWAS was significantly associated with PCOS risk, especially in the highest quartile subjects. This result suggests the possibility of early detection of PCOS in at-risk women. A relationship between the GRS and risk prediction was also reported for other diseases, including type 2 diabetes, obesity, atrial fibrillation and fatty liver disease (Belsky et al., 2013; Kwak et al., 2013; Tada et al., 2014; Leon-Mimila et al., 2015) .
In our study, the GRS also showed a significant association with PCOS-related traits. The representative characteristics of PCOS, such as hyperandrogenemia, oligomenorrhea and polycystic ovary morphology, showed graded associations with the GRS. Therefore, we subsequently explored the associations of the GRS with obesity, insulin resistance and dyslipidemia; however, we did not observe significant associations of the above traits with the GRS. Our GRS was constructed from the loci based on previous GWASs, and all women with PCOS in those GWASs were diagnosed by ESHRE criteria. This may be one reason why we observed such results.
We also compared GRS among four main PCOS phenotypes and controls. Women with PCOS could be divided into four subgroups under ESHRE criteria: (1) oligomenorrhea + hyperandrogenism + polycystic ovary, (2) oligomenorrhea + hyperandrogenism, (3) oligomenorrhea + polycystic ovary and (4) hyperandrogenism + polycystic ovary. The GRS was significantly higher in PCOS women with phenotype A and C than controls. The GRS of PCOS women with phenotype B and D did not differ from that of controls. Women who have both oligomenorrhea and polycystic ovaries had higher GRS than other subgroups and controls. Therefore, the current GRS has more powerful potential to screen the PCOS phenotype including oligomenorrhea and polycystic ovary morphology.
The clinical value of the GRS could be the ability to identify asymptomatic individuals among at-risk people and stratify them into accurate risk categories for the purpose of individualizing treatment approaches, which could potentially improve health outcomes. Therefore, the predictive model using the GRS is valuable, and reports have recently detailed its use in cardiovascular disease (Thanassoulis et al., 2012) , type 2 diabetes (Kwak et al., 2013 ) and large-for-gestational-age infants (Chawla et al., 2014) . We assessed the discriminative accuracy of the GRS in the prediction of PCOS risk based on the area under the curves (AUC), evaluated by receiver operating characteristic (ROC) curve analysis. Although a GRS of ≥12 was significantly associated with PCOS, the GRS showed a poor predictive value (AUC 0.575, 95% CI 0.548-0.602) in the ROC evaluation. Therefore, the use of genetic information based on current GWAS data only may present problems regarding the prediction of PCOS.
The strength of the present study is the carefully selected subjects. A homogenous group of PCOS women with well-defined diagnostic criteria were selected in this study. Additionally, we used the comprehensive GWAS data for the evaluation of the GRS. However, the study also had some limitations. We used 11 loci for the calculation of the GRS, but higher numbers of PCOS risk alleles have been reported in previous studies. Therefore, further studies could assess the value of the GRS, including the additional SNPs, related to PCOS. In addition, this study was conducted in a Korean population, so the GRS analysis of other ethnicities will be required to adapt this result to other populations. Additionally, this study was a cross-sectional study, and careful long-term observation may be required to assess disease outcome.
PCOS is the most common endocrine disease in reproductive-aged women and is a lifelong disorder with cardio-metabolic and reproductive implications, including obesity, type 2 diabetes, cardiovascular disease, impaired fertility and endometrial cancer. Therefore, a personalized and integrative approach and early detection model are highly important for optimizing treatment and preventing long-term health consequences.
In conclusion, a higher GRS was associated with PCOS risk and related traits, such as hyperandrogenemia, menstruation number/year and polycystic ovary morphology. Because genetic information cannot currently be used for disease prediction, future large prospective studies are needed to evaluate the utility of the GRS.
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